CERS
NASD Cerus Corporation$2.26 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.26, $0.04 below the day’s high of $2.30
- YTD change
- +9.71%
- vs 20-day SMA
- -8.50%
- vs 200-day SMA
- -7.26%
Price ranges
Price & Performance
+0.34 (+17.71%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.2% away from all-time highs of $81.88
- CERS is up 10% since the beginning of the year
- CERS is up 41% over the past 12 months
- CERS is down 9% over the past 1 month
CERS reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +44.9%.
- Previous minute
- +$0.00
- Last hour
- -$0.01
- Last 5 days
- -0.88%
- vs 8-day SMA
- -2.43%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.